{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T09:07:16Z","timestamp":1792487236151,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-025-00871-w","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T11:49:41Z","timestamp":1740052181000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Risk factors for gastrointestinal complications during glucocorticoid therapy in internal medicine inpatients: a real-world retrospective analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Pengpeng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,20]]},"reference":[{"issue":"10","key":"871_CR1","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1002\/art.42249","volume":"74","author":"Maarten Boers","year":"2022","unstructured":"Maarten Boers. Three months of glucocorticoids in Rheumatoid Arthritis: a Bridge too short? Arthritis Rheumatol. 2022;74(10):1609\u201311. https:\/\/doi.org\/10.1002\/art.42249.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"871_CR2","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.tem.2017.10.010","volume":"29","author":"J Vandewalle","year":"2018","unstructured":"Vandewalle J, Luypaert A, De Bosscher K, Libert C. Therapeutic mechanisms of glucocorticoids. Trends Endocrinol Metab. 2018;29(1):42\u201354. https:\/\/doi.org\/10.1016\/j.tem.2017.10.010.","journal-title":"Trends Endocrinol Metab"},{"key":"871_CR3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.pharmthera.2015.05.001","volume":"152","author":"J Nora Sundahl","year":"2015","unstructured":"Nora Sundahl, Jolien Bridelance, Claude Libert, Karolien De Bosscher, Ilse M Beck. Selective glucocorticoid receptor modulation: new directions with non-steroidal scaffolds. Pharmacol Ther. 2015;152:28\u201341. https:\/\/doi.org\/10.1016\/j.pharmthera.2015.05.001.","journal-title":"Pharmacol Ther"},{"issue":"4","key":"871_CR4","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1517\/14740338.2016.1140743","volume":"15","author":"M Oray","year":"2016","unstructured":"Oray M, Abu Samra K, Ebrahimiadib N, Meese H, Foster CS. Long-term side effects of glucocorticoids. Expert Opin Drug Saf. 2016;15(4):457\u201365. https:\/\/doi.org\/10.1517\/14740338.2016.1140743.","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"871_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jaad.2016.02.1239","volume":"76","author":"A Caplan","year":"2017","unstructured":"Caplan A, Fett N, Rosenbach M, Werth VP, Micheletti RG. Prevention and management of glucocorticoid-induced side effects: a comprehensive review: gastrointestinal and endocrinologic side effects. J Am Acad Dermatol. 2017;76(1):11\u20136. https:\/\/doi.org\/10.1016\/j.jaad.2016.02.1239.","journal-title":"J Am Acad Dermatol"},{"issue":"2 Pt 1","key":"871_CR6","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/s0190-9622(86)70018-2","volume":"14","author":"C Gallant","year":"1986","unstructured":"Gallant C, Kenny P. Oral glucocorticoids and their complications. A review. J Am Acad Dermatol. 1986;14(2 Pt 1):161\u201377. https:\/\/doi.org\/10.1016\/s0190-9622(86)70018-2.","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"871_CR7","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1046\/j.1365-2036.2002.01279.x","volume":"16","author":"JC Luo","year":"2002","unstructured":"Luo JC, Chang FY, Lin HY, Lu RH, Lu CL, Chen C-Y, et al. The potential risk factors leading to peptic ulcer formation in autoimmune disease patients receiving corticosteroid treatment. Aliment Pharmacol Ther. 2002;16(7):1241\u20138. https:\/\/doi.org\/10.1046\/j.1365-2036.2002.01279.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"871_CR8","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s40264-018-0645-3","volume":"41","author":"D Reinau","year":"2018","unstructured":"Reinau D, Schwenkglenks M, Fr\u00fch M, Signorell A, Blozik E, Meier CR. Glucocorticoids and the risk of peptic ulcer bleeding: case\u2013control analysis based on Swiss Claims Data. Drug Saf. 2018;41(7):725\u201330. https:\/\/doi.org\/10.1007\/s40264-018-0645-3.","journal-title":"Drug Saf"},{"issue":"1","key":"871_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/s0163-7258(02)00297-8","volume":"96","author":"H Sch\u00e4cke","year":"2002","unstructured":"Sch\u00e4cke H, D\u00f6cke WD, Asadullah K. Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther. 2002;96(1):23\u201343. https:\/\/doi.org\/10.1016\/s0163-7258(02)00297-8.","journal-title":"Pharmacol Ther"},{"issue":"5","key":"871_CR10","doi-asserted-by":"publisher","first-page":"e004587","DOI":"10.1136\/bmjopen-2013-004587","volume":"4","author":"S Narum","year":"2014","unstructured":"Narum S, Westergren T, Klemp M. Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis. BMJ Open. 2014;4(5):e004587. https:\/\/doi.org\/10.1136\/bmjopen-2013-004587.","journal-title":"BMJ Open"},{"issue":"6","key":"871_CR11","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/j.1365-2796.1994.tb00855.x","volume":"236","author":"HO Conn","year":"1994","unstructured":"Conn HO, Poynard T. Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy. J Intern Med. 1994;236(6):619\u201332. https:\/\/doi.org\/10.1111\/j.1365-2796.1994.tb00855.x.","journal-title":"J Intern Med"},{"issue":"9","key":"871_CR12","doi-asserted-by":"publisher","first-page":"CD004405","DOI":"10.1002\/14651858.CD004405.pub5","volume":"2015","author":"MC Brouwer","year":"2015","unstructured":"Brouwer MC, McIntyre P, Prasad K, van de Beek D. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015;2015(9):CD004405. https:\/\/doi.org\/10.1002\/14651858.CD004405.pub5.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"871_CR13","doi-asserted-by":"publisher","first-page":"CD000196","DOI":"10.1002\/14651858.CD000196.pub2","volume":"2005","author":"P Alderson","year":"2005","unstructured":"Alderson P, Roberts I. Corticosteroids for acute traumatic brain injury. Cochrane Database Syst Rev. 2005;2005(1):CD000196. https:\/\/doi.org\/10.1002\/14651858.CD000196.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"871_CR14","doi-asserted-by":"publisher","first-page":"735","DOI":"10.7326\/0003-4819-114-9-735","volume":"114","author":"JM Piper","year":"1991","unstructured":"Piper JM, Ray WA, Daugherty JR, Griffin MR. Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs. Ann Intern Med. 1991;114(9):735\u201340. https:\/\/doi.org\/10.7326\/0003-4819-114-9-735.","journal-title":"Ann Intern Med"},{"issue":"3","key":"871_CR15","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0002-9343(91)90119-i","volume":"91","author":"JL Carson","year":"1991","unstructured":"Carson JL, Strom BL, Schinnar R, Duff A, Sim E. The low risk of upper gastrointestinal bleeding in patients dispensed corticosteroids. Am J Med. 1991;91(3):223\u20138. https:\/\/doi.org\/10.1016\/0002-9343(91)90119-i.","journal-title":"Am J Med"},{"issue":"11","key":"871_CR16","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1007\/s00134-019-05754-3","volume":"45","author":"E Butler","year":"2019","unstructured":"Butler E, M\u00f8ller MH, Cook O, Granholm A, Penketh J, Ryg\u00e5rd SL, et al. The effect of systemic corticosteroids on the incidence of gastrointestinal bleeding in critically ill adults: a systematic review with meta-analysis. Intensive Care Med. 2019;45(11):1540\u20139. https:\/\/doi.org\/10.1007\/s00134-019-05754-3.","journal-title":"Intensive Care Med"},{"issue":"7","key":"871_CR17","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/s0002-9343(01)00941-x","volume":"111","author":"GL Nielsen","year":"2001","unstructured":"Nielsen GL, S\u00f8rensen HT, Mellemkjoer L, Blot WJ, McLaughlin JK, Tage-Jensen U, et al. Risk of hospitalization resulting from upper gastrointestinal bleeding among patients taking corticosteroids: a register-based cohort study. Am J Med. 2001;111(7):541\u20135. https:\/\/doi.org\/10.1016\/s0002-9343(01)00941-x.","journal-title":"Am J Med"},{"issue":"1","key":"871_CR18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s40360-021-00530-w","volume":"22","author":"PP Liu","year":"2021","unstructured":"Liu PP, Li GY, Han M, Zhang C. Identification and solution of drug-related problems in the neurology unit of a tertiary hospital in China. BMC Pharmacol Toxicol. 2021;22(1):65. https:\/\/doi.org\/10.1186\/s40360-021-00530-w.","journal-title":"BMC Pharmacol Toxicol"},{"key":"871_CR19","doi-asserted-by":"publisher","first-page":"1418086","DOI":"10.3389\/fphar.2024.1418086","volume":"15","author":"PP Liu","year":"2024","unstructured":"Liu PP, Li GY, Wu Q, Han M. Current status and influencing factors of prophylactic use of proton pump inhibitors in internal medicine inpatients receiving glucocorticoid therapy. Front Pharmacol. 2024;15:1418086. https:\/\/doi.org\/10.3389\/fphar.2024.1418086.","journal-title":"Front Pharmacol"},{"issue":"11","key":"871_CR20","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1093\/aje\/153.11.1089","volume":"153","author":"S Hern\u00e1ndez-D\u00edaz","year":"2001","unstructured":"Hern\u00e1ndez-D\u00edaz S, Rodr\u00edguez LA. Steroids and risk of upper gastrointestinal complications. Am J Epidemiol. 2001;153(11):1089\u201393. https:\/\/doi.org\/10.1093\/aje\/153.11.1089.","journal-title":"Am J Epidemiol"},{"issue":"3","key":"871_CR21","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/ajg.2009.115","volume":"104","author":"FL Lanza","year":"2009","unstructured":"Lanza FL, Chan FK, Quigley EM, Practice Parameters Committee of the American College of Gastroenterology. Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol. 2009;104(3):728\u201338. https:\/\/doi.org\/10.1038\/ajg.2009.115.","journal-title":"Am J Gastroenterol"},{"issue":"14","key":"871_CR22","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","volume":"42","author":"JP Collet","year":"2021","unstructured":"Collet JP, Thiele H, Barbato E, Barth\u00e9l\u00e9my O, Bauersachs J, Bhatt DL, et al. 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42(14):1289\u2013367. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa575.","journal-title":"Eur Heart J"},{"issue":"7","key":"871_CR23","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nrgastro.2011.97","volume":"8","author":"C Sostres","year":"2011","unstructured":"Sostres C, Lanas A. Gastrointestinal effects of aspirin. Nat Rev Gastroenterol Hepatol. 2011;8(7):385\u201394. https:\/\/doi.org\/10.1038\/nrgastro.2011.97.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"9","key":"871_CR24","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/apt.12483","volume":"38","author":"CC Lin","year":"2013","unstructured":"Lin CC, Hu HY, Luo JC, Peng YL, Hou MC, Lin HC, et al. Risk factors of gastrointestinal bleeding in clopidogrel users: a nationwide population-based study. Aliment Pharmacol Ther. 2013;38(9):1119\u201328. https:\/\/doi.org\/10.1111\/apt.12483.","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"871_CR25","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1111\/jvim.15577","volume":"33","author":"JC Whittemore","year":"2019","unstructured":"Whittemore JC, Mooney AP, Price JM, Thomason J. Clinical, clinicopathologic, and gastrointestinal changes from aspirin, prednisone, or combination treatment in healthy research dogs: a double-blind randomized trial. J Vet Intern Med. 2019;33(5):1977\u201387. https:\/\/doi.org\/10.1111\/jvim.15577.","journal-title":"J Vet Intern Med"},{"issue":"6","key":"871_CR26","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1111\/jvim.15630","volume":"33","author":"JC Whittemore","year":"2019","unstructured":"Whittemore JC, Mooney AP, Price JM, Thomason J. Clinical, clinicopathologic, and gastrointestinal changes from administration of clopidogrel, prednisone, or combination in healthy dogs: a double-blind randomized trial. J Vet Intern Med. 2019;33(6):2618\u201327. https:\/\/doi.org\/10.1111\/jvim.15630.","journal-title":"J Vet Intern Med"},{"issue":"5","key":"871_CR27","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.cgh.2016.12.033","volume":"15","author":"M Vaduganathan","year":"2017","unstructured":"Vaduganathan M, Bhatt DL. Gastrointestinal bleeding with oral anticoagulation: understanding the scope of the Problem. Clin Gastroenterol Hepatol. 2017;15(5):691\u20133. https:\/\/doi.org\/10.1016\/j.cgh.2016.12.033.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"871_CR28","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1160\/TH13-02-0150","volume":"110","author":"J Desai","year":"2013","unstructured":"Desai J, Kolb JM, Weitz JI, Aisenberg J. Gastrointestinal bleeding with the new oral anticoagulants\u2013defining the issues and the management strategies. Thromb Haemost. 2013;110(2):205\u201312. https:\/\/doi.org\/10.1160\/TH13-02-0150.","journal-title":"Thromb Haemost"},{"issue":"8","key":"871_CR29","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1136\/heartjnl-2021-319503","volume":"108","author":"A Holt","year":"2022","unstructured":"Holt A, Blanche P, Zareini B, Rasmussen PV, Strange JE, Rajan D, et al. Gastrointestinal bleeding risk following concomitant treatment with oral glucocorticoids in patients on non-vitamin K oral anticoagulants. Heart. 2022;108(8):626\u201332. https:\/\/doi.org\/10.1136\/heartjnl-2021-319503.","journal-title":"Heart"},{"issue":"1","key":"871_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1056\/NEJM198307073090105","volume":"309","author":"J Messer","year":"1983","unstructured":"Messer J, Reitman D, Sacks HS, Smith H, Chalmers TC. Association of adrenocorticosteroid therapy and peptic-ulcer disease. N Engl J Med. 1983;309(1):21\u20134. https:\/\/doi.org\/10.1056\/NEJM198307073090105.","journal-title":"N Engl J Med"},{"issue":"11","key":"871_CR31","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1007\/s10620-018-5209-y","volume":"63","author":"Y Kondo","year":"2018","unstructured":"Kondo Y, Hatta W, Koike T, Takahashi Y, Saito M, Kanno T, et al. The Use of higher dose steroids increases the risk of rebleeding after endoscopic hemostasis for peptic ulcer bleeding. Dig Dis Sci. 2018;63(11):3033\u201340. https:\/\/doi.org\/10.1007\/s10620-018-5209-y.","journal-title":"Dig Dis Sci"},{"issue":"5","key":"871_CR32","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/apt.13298","volume":"42","author":"CL Tseng","year":"2015","unstructured":"Tseng CL, Chen YT, Huang CJ, Luo JC, Peng YL, Huang DF, et al. Short-term use of glucocorticoids and risk of peptic ulcer bleeding: a nationwide population-based case-crossover study. Aliment Pharmacol Ther. 2015;42(5):599\u2013606. https:\/\/doi.org\/10.1111\/apt.13298.","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"871_CR33","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1056\/NEJM197602262940905","volume":"294","author":"HO Conn","year":"1976","unstructured":"Conn HO, Blitzer BL. Nonassociation of adrenocorticosteroid therapy and peptic ulcer. N Engl J Med. 1976;294(9):473\u20139. https:\/\/doi.org\/10.1056\/NEJM197602262940905.","journal-title":"N Engl J Med"},{"issue":"1","key":"871_CR34","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13741-024-00376-w","volume":"13","author":"PP Liu","year":"2024","unstructured":"Liu PP, Li GY, Wu Q, Han M, Zhang C. Analysis of inappropriate prophylactic use of proton pump inhibitors during the perioperative period: an observational study. Perioper Med (Lond). 2024;13(1):19. https:\/\/doi.org\/10.1186\/s13741-024-00376-w.","journal-title":"Perioper Med (Lond)"},{"key":"871_CR35","doi-asserted-by":"publisher","unstructured":"Chinese Society of Endocrinology. Principles for clinical application of glucocorticoids (2023 edition). Chin J Endocrinol Metab. 2023;39(4):289\u201396. https:\/\/doi.org\/10.3760\/cma.j.cn311282-20230116-00029","DOI":"10.3760\/cma.j.cn311282-20230116-00029"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-00871-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-025-00871-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-00871-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T11:49:43Z","timestamp":1740052183000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-025-00871-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,20]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["871"],"URL":"https:\/\/doi.org\/10.1186\/s40360-025-00871-w","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,20]]},"assertion":[{"value":"8 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the Declaration of Helsinki and approved by the Beijing Tongren Hospital Ethics Committee (NO. TREC2024-KY065). Patients were exempt from informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All methods were carried out in accordance with relevant guidelines and regulations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37"}}